Prediction of the 10-year probability of gastric cancer occurrence in the Japanese population: The JPHC study cohort II

International Journal of Cancer

Volumn 138, Issue 2, 2016, Pages 320-331

  Charvat, Hadrien ^a   Sasazuki, Shizuka ^a   Inoue, Manami ^a,b   Iwasaki, Motoki ^a   Sawada, Norie ^a   Shimazu, Taichi ^a   Yamaji, Taiki ^a   Tsugane, Shoichiro ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

gastric cancer; Helicobacter pylori; pepsinogen; prediction model

Indexed keywords

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT ANALYSIS; COMPLICATION; FEMALE; HELICOBACTER INFECTIONS; HUMAN; JAPAN; LIFESTYLE; MALE; MIDDLE AGED; PROBABILITY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; STOMACH NEOPLASMS;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; FEMALE; HELICOBACTER INFECTIONS; HUMANS; JAPAN; LIFE STYLE; MALE; MIDDLE AGED; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84955636803     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29705     Document Type: Article

References (46)

1. Ferlay J, Soerjomataram I, Ervik M, et al., GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer, 2013. Available at: http://globocan.iarc.fr (Accessed September 3, 2014).
2. Inoue M, Tsugane S., Epidemiology of gastric cancer in Japan. Postgrad Med J 2005; 81: 419-24.
3. Cancer Statistics in Japan, 2014. Available at: http://ganjoho.jp/public/statistics/pub/statistics01.html (Accessed September 18, 2014).
4. Uemura N, Okamoto S, Yamamoto S, et al., Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
5. Conteduca V, Sansonno D, Lauletta G, et al., H. pylori infection and gastric cancer: state of the art (review). Int J Oncol 2013; 42: 5-18.
6. de Martel C, Ferlay J, Franceschi S, et al., Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012; 13: 607-15.
7. Plummer M, Franceschi S, Vignat J, et al., Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer 2015; 136: 487-90.
8. Brenner H, Arndt V, Stegmaier C, et al., Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? Am J Epidemiol 2004; 159: 252-8.
9. Miki K., Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels-"ABC method." Proc Jpn Acad Ser B Phys Biol Sci 2011; 87: 405-14.
10. Watabe H, Mitsushima T, Yamaji Y, et al., Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005; 54: 764.
11. Brenner H, Arndt V, Bode G, et al., Risk of gastric cancer among smokers infected with Helicobacter pylori. Int J Cancer 2002; 98: 446-9.
12. Sasazuki S, Sasaki S, Tsugane S,; Japan Public Health Center Study Group. Cigarette smoking, alcohol consumption and subsequent gastric cancer risk by subsite and histologic type. Int J Cancer 2002; 101: 560.
13. Nishino Y, Inoue M, Tsuji I, et al.,; Research Group for the Development Evaluation of Cancer Prevention Strategies in Japan. Tobacco smoking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2006; 36: 800-7.
14. Tsugane S, Sasazuki S, Kobayashi M, et al., Salt and salted food intake and subsequent risk of gastric cancer among middle-aged Japanese men and women. Br J Cancer 2004; 90: 128-34.
15. Kobayashi M, Tsubono Y, Sasazuki S, et al.,; JPHC Study Group. Vegetables, fruit and risk of gastric cancer in Japan: a 10-year follow-up of the JPHC Study Cohort I. Int J Cancer 2002; 102: 39-44.
16. Shimazu T, Wakai K, Tamakoshi A, et al.,; Research Group for the Development Evaluation of Cancer Prevention Strategies in Japan. Association of vegetable and fruit intake with gastric cancer risk among Japanese: a pooled analysis of four cohort studies. Ann Oncol 2014; 25: 1228-33.
17. Tsugane S, Sasazuki S., Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 2007; 10: 75-83.
18. Buckland G, Travier N, Huerta JM, et al., Healthy lifestyle index and risk of gastric adenocarcinoma in the EPIC cohort study. Int J Cancer 2015; 137: 598-606.
19. Lee TY, Wang CB, Chen TT, et al.,; Taiwan Gastrointestinal Disease Helicobacter Consortium. A tool to predict risk for gastric cancer in patients with peptic ulcer disease on the basis of a nationwide cohort. Clin Gastroenterol Hepatol 2015; 13: 287-93.
20. Tata MD, Gurunathan R, Palayan K., MARK's quadrant scoring system: a symptom-based targeted screening tool for gastric cancer. Ann Gastroenterol 2014; 27: 34-41.
21. Mizuno S, Miki I, Ishida T, et al., Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis. Dig Dis Sci 2010; 55: 3132-7.
22. Yoshida T, Kato J, Inoue I, et al., Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Int J Cancer 2014; 134: 1445-57.
23. Hamashima C, Shibuya D, Yamazaki H, et al., The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 2008; 38: 259-67.
24. Suenaga I, Sasazuki S, Tsugane S., Further study of translational research for preventive medicine. Prev Med 2012; 55: 573-4.
25. Tsugane S, Sobue T., Baseline survey of JPHC study-design and participation rate. Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases. J Epidemiol 2001; 11: S24 -S2 9.
26. World Health Organization. International classification of diseases for oncology, 3rd edn. Geneva, Switzerland: World Health Organization, 2000. 240 p.
27. Tramacere I, Negri E, Pelucchi C, et al., A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol 2012; 23: 28-36.
28. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity and the prevention of cancer: a global perspective. Washington, DC: AICR, 2007. 517 p.
29. Yaghoobi M, Bijarchi R, Narod SA., Family history and the risk of gastric cancer. Br J Cancer 2010; 102: 237-42.
30. Grambsch PM, Therneau TM., Proportional hazard tests and diagnostics based on weighted residuals. Biometrika 1994; 81: 515-26.
31. Remontet L, Bossard N, Belot A, et al.,; French Network of Cancer Registries FRANCIM. An overall strategy based on regression models to estimate relative survival and model the effects of prognostic factors in cancer survival studies. Stat Med 2007; 26: 2214-28.
32. Charvat H, Sasazuki S, Inoue M, et al.,; JPHC Study Group. Impact of five modifiable lifestyle habits on the probability of cancer occurrence in a Japanese population-based cohort: results from the JPHC study. Prev Med 2013; 57: 685-9.
33. Moons KG, Kengne AP, Woodward M, et al., Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart 2012; 98: 683-90.
34. Harrell FE, Jr, Lee KL, Mark DB., Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-87.
35. Pencina MJ, d'Agostino RB., Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 2004; 23: 2109-23.
36. Antolini L, Boracchi P, Biganzoli E., A time-dependent discrimination index for survival data. Stat Med 2005; 24: 3927-44.
37. D'Agostino RB, Nam BH., Evaluation of the performance of survival analysis models: discrimination and calibration measures. In:, Balakrishnan N, Rao CR, eds. Handbook of statistics, vol. 23. Amsterdam: Elsevier, 2004. 1-25.
38. Sullivan LM, Massaro JM, d'Agostino RB. Sr., Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med 2004; 23: 1631-60.
39. D'Agostino RB, Vasan RS, Pencina MJ, et al., General cardiovascular risk profile for use in primary care. Circulation 2008; 117: 743-53.
40. Terasawa T, Nishida H, Kato K, et al., Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: a systematic review and meta-analysis. PLoS One 2014; 9: e109783.
41. Tatemichi M, Sasazuki S, Inoue M, et al.,; JPHC Study Group. Clinical significance of IgG antibody titer against Helicobacter pylori. Helicobacter 2009; 14: 231-6.
42. Altman DG, Lausen B, Sauerbrei W, et al., Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 1994; 86: 829-35.
43. Lausen B, Schumacher M., Evaluating the effect of optimized cutoff values in the assessment of prognostic factors. Comput Stat Data Anal 1996; 21: 307-26.
44. Royston P, Altman DG., External validation of a Cox prognostic model: principles and methods. BMC Med Res Methodol 2013; 13: 33.
45. Moons KG, Kengne AP, Grobbee DE, et al., Risk prediction models: II. External validation, model updating, and impact assessment. Heart 2012; 98: 691-8.
46. Iwasaki M, Yamamoto S, Otani T, et al.,; Japan Public Health Center-based Prospective Study Group. Generalizability of relative risk estimates from a well-defined population to a general population. Eur J Epidemiol 2006; 21: 253-62.